Where I see patients (1)
My reviews
Selected research
- 
							Single-center experience with nelarabine, etoposide, and cyclophosphamide in adults with relapsed/refractory T-acute lymphoblastic leukemia/lymphoma.
							Leukemia & lymphoma
 - 
							The Irreversible FLT3 Inhibitor FF-10101 Is Active Against a Diversity of FLT3 Inhibitor Resistance Mechanisms.
							Molecular cancer therapeutics
 - 
							Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia.
							Cancer discovery
 
					
				
														
														
														
														
														
				
					
				
4.8